6849.T Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 09:15):

Stats
Объем за сегодня	238 700
Средний объем	235 767
Рыночная капитализация	359.31B
EPS	¥0 ( 2024-02-01 )
Дата следующего отчета о доходах	( ¥87.32 ) 2024-05-12
Last Dividend	¥41.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	22.22
ATR14	¥1.812 (0.04%)

Объем Корреляция

Длинно: 0.12 (neutral)

Кратко: -0.51 (weak negative)

Signal:(44.692) Neutral

Nihon Kohden Corporation Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Nihon Kohden Corporation Корреляция - Валюта/Сырье

-0.25
( neutral )

-0.15
( neutral )

-0.14
( neutral )

-0.26
( neutral )

0.07
( neutral )

0.66
( moderate )

Nihon Kohden Corporation Финансовые показатели

Annual	2022
Выручка:	¥206.60B
Валовая прибыль:	¥105.93B (51.27 %)
EPS:	¥203.28

FY	2022
Выручка:	¥206.60B
Валовая прибыль:	¥105.93B (51.27 %)
EPS:	¥203.28

FY	2022
Выручка:	¥205.13B
Валовая прибыль:	¥109.09B (53.18 %)
EPS:	¥276.51

FY	2021
Выручка:	¥199.73B
Валовая прибыль:	¥102.23B (51.19 %)
EPS:	¥214.21

Financial Reports:

No articles found.

Nihon Kohden Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥20.00 (N/A)	¥0 (N/A)	¥41.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Nihon Kohden Corporation Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.53 - Stable (10.57%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.250	2001-03-27
Last Dividend	¥41.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥558.75	--
Avg. Dividend % Per Year	0.00%	--
Score	3.98	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.53
Div. Directional Score	8.39	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

3.98

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8136.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
7483.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6707.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
6058.T	Ex Dividend Junior	2024-02-28	Sporadic	0.00%
4733.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3981.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
3186.T	Ex Dividend Junior	2023-11-29	Annually	0.00%
2180.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
9052.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
7942.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0741	1.500	8.52	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0750	1.200	7.50	9.00	[0 - 0.3]
returnOnEquityTTM	0.0947	1.500	-0.0584	-0.0877	[0.1 - 1]
payoutRatioTTM	0.369	-1.000	6.31	-6.31	[0 - 1]
currentRatioTTM	4.03	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.43	0.800	0.425	0.340	[0.8 - 2.5]
cashRatioTTM	0.769	1.500	6.84	10.00	[0.2 - 2]
debtRatioTTM	0.00205	-1.500	9.97	-10.00	[0 - 0.6]
interestCoverageTTM	1 558.31	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	168.66	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	71.40	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.00258	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.507	1.000	4.88	4.88	[0.2 - 0.8]
operatingProfitMarginTTM	0.0928	1.000	-0.143	-0.143	[0.1 - 0.6]
cashFlowToDebtRatioTTM	32.11	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.011	0.800	6.59	5.27	[0.5 - 2]
Total Score				11.26

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	22.21	1.000	7.86	0	[1 - 100]
returnOnEquityTTM	0.0947	2.50	-0.0376	-0.0877	[0.1 - 1.5]
freeCashFlowPerShareTTM	71.40	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.429	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	168.66	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.369	1.500	6.31	-6.31	[0 - 1]
pegRatioTTM	1.107	1.500	5.95	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0650	1.000	-0.874	0	[0.1 - 0.5]
Total Score				5.53

Nihon Kohden Corporation

Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.